Skip to main content

Kodiak AI, Inc.

For the period ended Sep 30, 2026. Filed Nov 6, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2026 · Filed Nov 6, 2026

KDK$1.21-16.6%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Consolidated Statements of Cash Flows

Nine Months Ended September 30,
20262025
Operating activities:
Net (loss) income$66,381$(511,846)
Adjustments to reconcile net (loss) income to net cash used in operating activities:
Depreciation and amortization4,9492,124
Stock-based compensation21,22910,136
Non-cash lease expense1,5881,372
Accretion of discount on marketable securities(1,057)—
Transaction costs allocated to common stock warrants1,9843,223
Change in fair value of second lien loans1,76023,938
Change in fair value of simple agreements for future equity—190,075
Change in fair value of redeemable convertible preferred stock warrant liabilities—7,272
Change in fair value of common stock warrants(201,151)—
Loss on issuance of equity instruments—210,722
Non-cash interest expense346641
(Gain) loss on disposal of property and equipment, net(88)130
Changes in operating assets and liabilities:
Accounts receivable602574
Prepaid expenses and other current assets(195)(2,596)
Other assets(47)—
Accounts payable(185)(239)
Accrued expenses and other current liabilities6,440(4,589)
Operating lease liabilities(1,566)(1,369)
Other liabilities169216
Net cash used in operating activities(98,841)(70,216)
Investing activities:
Proceeds from maturities of marketable securities92,267—
Proceeds from sales of property and equipment684—
Purchases of marketable securities(104,193)—
Purchases of property and equipment(12,246)(11,881)
Net cash used in investing activities(23,488)(11,881)
Financing activities:
Repayment of debt(1,213)(11,776)
Proceeds from issuance of second lien loans—43,865
Proceeds from issuance of simple agreements for future equity—23,660
Proceeds from issuance of Series A cumulative redeemable convertible preferred stock—145,000
Proceeds from the reverse recapitalization, net of transaction costs—26,239
Proceeds from issuance of common stock and warrants in connection with a private placement100,000—
Proceeds from exercise of stock options2,0351,221
Proceeds from exercise of common stock warrants7,156—
Payments of offering costs(5,527)(16,618)
Net cash provided by financing activities102,451211,591
Net change in cash and cash equivalents and restricted cash(19,878)129,494
Cash and cash equivalents and restricted cash at beginning of period52,21118,159
Cash and cash equivalents and restricted cash at end of period$32,333$147,653
Components of cash and restricted cash at period end:
Cash and cash equivalents$30,883$146,203
Restricted cash included in prepaid and other current assets500—
Restricted cash9501,450
Total cash and cash equivalents and restricted cash$32,333$147,653
Supplemental disclosure of cash activities:
Cash paid for interest$2,396$2,733
Cash paid for income taxes$10$—
Supplemental disclosure of non-cash activities:
Purchases of property and equipment included in accounts payable and accrued expenses and other current liabilities$689$2,947
Operating lease right-of-use asset obtained in exchange for operating lease liability upon modification of operating lease$720$—
Operating lease right-of-use asset obtained in exchange for operating lease liability upon new operating lease$497$—
Proceeds from exercise of stock options included in prepaid and other current assets$664$—
Conversion of simple agreements for future equity into common stock in connection with reverse recapitalization$—$263,036
Conversion of redeemable preferred stock into common stock in connection with reverse recapitalization$—$170,648
Conversion of second lien loans into common stock in connection with reverse recapitalization$—$67,379
Settlement of transaction costs in common stock in connection with reverse recapitalization$—$12,500
Exchange of simple agreements for future equity for second lien loan$—$10,000
Net exercise of warrants in connection with reverse recapitalization$—$8,891
Issuance of non-redemption common stock in connection with reverse recapitalization$—$3,220
Liabilities assumed from reverse recapitalization$—$31
Offering costs included in accounts payable and accrued liabilities and other current liabilities$—$159
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.